Fragile X Mental Retardation Protein
"Fragile X Mental Retardation Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.
Descriptor ID |
D051860
|
MeSH Number(s) |
D12.776.157.725.061 D12.776.631.299 D12.776.664.962.124
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fragile X Mental Retardation Protein".
Below are MeSH descriptors whose meaning is more specific than "Fragile X Mental Retardation Protein".
This graph shows the total number of publications written about "Fragile X Mental Retardation Protein" by people in this website by year, and whether "Fragile X Mental Retardation Protein" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 3 | 3 |
1996 | 0 | 3 | 3 |
1998 | 0 | 2 | 2 |
1999 | 0 | 7 | 7 |
2000 | 0 | 4 | 4 |
2001 | 0 | 7 | 7 |
2002 | 0 | 5 | 5 |
2003 | 0 | 11 | 11 |
2004 | 1 | 17 | 18 |
2005 | 3 | 11 | 14 |
2006 | 11 | 5 | 16 |
2007 | 12 | 10 | 22 |
2008 | 12 | 7 | 19 |
2009 | 18 | 4 | 22 |
2010 | 11 | 8 | 19 |
2011 | 27 | 8 | 35 |
2012 | 27 | 12 | 39 |
2013 | 18 | 8 | 26 |
2014 | 18 | 6 | 24 |
2015 | 5 | 11 | 16 |
2016 | 21 | 7 | 28 |
2017 | 11 | 9 | 20 |
2018 | 11 | 10 | 21 |
2019 | 7 | 4 | 11 |
2020 | 11 | 8 | 19 |
2021 | 5 | 17 | 22 |
2022 | 6 | 14 | 20 |
2023 | 2 | 17 | 19 |
2024 | 10 | 7 | 17 |
Below are the most recent publications written about "Fragile X Mental Retardation Protein" by people in Profiles.
-
Somatic Instability Leading to Mosaicism in Fragile X Syndrome and Associated Disorders: Complex Mechanisms, Diagnostics, and Clinical Relevance. Int J Mol Sci. 2024 Dec 21; 25(24).
-
Parkinson's Disease Polygenic Risk Score and Neurological Involvement in Carriers of the FMR1 Premutation Allele: A Case for Genetic Modifier. Mol Genet Genomic Med. 2024 Nov; 12(11):e70043.
-
Population-based FMR1 carrier screening among reproductive women. J Assist Reprod Genet. 2024 Nov; 41(11):3237-3243.
-
Knowledge and perceptions about fragile X syndrome and fragile X-premutation-associated conditions among medical doctors in Nigeria. Clin Genet. 2025 Jan; 107(1):56-66.
-
Language use predicts symptoms of fragile X-associated tremor/ataxia syndrome in men and women with the FMR1 premutation. Sci Rep. 2024 09 05; 14(1):20707.
-
Psychiatric Manifestations in Early to Middle Stages of Fragile X-Associated Tremor-Ataxia Syndrome (FXTAS). J Neuropsychiatry Clin Neurosci. 2025; 37(1):20-28.
-
FMR1 allelic complexity in premutation carriers provides no evidence for a correlation with age at amenorrhea. Reprod Biol Endocrinol. 2024 Jun 21; 22(1):71.
-
A Comprehensive Review of Fragile X Syndrome and Fragile X Premutation Associated Conditions in Africa. Genes (Basel). 2024 May 25; 15(6).
-
Enlarged perivascular spaces and their association with motor, cognition, MRI markers and cerebrovascular risk factors in male fragile X premutation carriers. J Neurol Sci. 2024 Jun 15; 461:123056.
-
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X-associated tremor/ataxia syndrome. Ann Clin Transl Neurol. 2024 Jun; 11(6):1420-1429.